L3VLUP
ProSign in

ALC · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ALCJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ALC
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterALCJNJ
Q3 202012 holders, $2.5bn30 holders, $26.2bn
Q4 202011 holders, $2.1bn32 holders, $26.6bn
Q1 202113 holders, $2.2bn31 holders, $25.3bn
Q2 20218 holders, $1.7bn37 holders, $25.6bn
Q3 20217 holders, $2.2bn40 holders, $24.1bn
Q4 20217 holders, $2.4bn33 holders, $25.2bn
Q1 20228 holders, $3.0bn35 holders, $28.2bn
Q2 20227 holders, $2.4bn33 holders, $26.9bn
Q3 202210 holders, $1.0bn36 holders, $25.4bn
Q4 202213 holders, $1.4bn35 holders, $27.6bn
Q1 202313 holders, $1.4bn42 holders, $24.5bn
Q2 202311 holders, $1.6bn38 holders, $25.0bn
Q3 202312 holders, $1.4bn37 holders, $18.9bn
Q4 202311 holders, $1.1bn31 holders, $19.0bn
Q1 20249 holders, $1.7bn32 holders, $19.7bn
Q2 20248 holders, $1.9bn35 holders, $20.4bn
Q3 202410 holders, $2.5bn28 holders, $22.3bn
Q4 202410 holders, $2.4bn37 holders, $20.4bn
Q1 202518 holders, $3.3bn32 holders, $20.5bn
Q2 202511 holders, $2.9bn31 holders, $18.4bn
Q3 202512 holders, $2.2bn32 holders, $23.7bn
Q4 202512 holders, $1.7bn29 holders, $27.8bn
Q1 20269 holders, $1.3bn34 holders, $35.6bn
Q2 20268 holders, $1.0bn33 holders, $39.1bn
ALC

Alcon AG

Holders
11
Reported value
$2.9bn
Buyers
7
Sellers
7

Breadth 0 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
31
Reported value
$18.4bn
Buyers
15
Sellers
16

Breadth -1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 34 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ALC (3)

Davidson Kempner Capital Management LP, Rokos Capital Management LLP, Schonfeld Strategic Advisors LLC

Only JNJ (23)

Acadian Asset Management LLC, AQR Capital Management LLC, Arrowstreet Capital LP, Brevan Howard Capital Management LP, Bridgewater Associates LP, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, GAMCO Investors Inc, Invesco Ltd, Man Group PLC, Markel Group Inc, MFS Investment Management, Millennium Management LLC, Point72 Asset Management LP, Quantbot Technologies LP, Renaissance Technologies LLC, Two Sigma Investments LP, Verition Fund Management LLC, Wellington Management Group LLP, Winton Group Ltd, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →